WEDNESDAY, June 26, 2024 -- Benralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not...
Vous n'êtes pas connecté
THURSDAY, June 27, 2024 -- For children with eosinophilic esophagitis, dupilumab results in a significantly higher percentage of histologic remission, according to a study published in the June 27 issue of the New England Journal of Medicine. Mirna...
WEDNESDAY, June 26, 2024 -- Benralizumab yields a greater histologic response than placebo for patients with eosinophilic esophagitis, but does not...
THURSDAY, June 20, 2024 -- Reteplase is noninferior to alteplase for patients with ischemic stroke within 4.5 hours after symptom onset, according to...
THURSDAY, June 20, 2024 -- Cognitive impairment is delayed among persons who are heterozygous for the apolipoprotein E3 Christchurch variant...
THURSDAY, June 27, 2024 -- In a policy statement issued by the American Academy of Pediatrics and published online June 27 in Pediatrics,...
WEDNESDAY, June 19, 2024 -- Drug-related infant mortality increased significantly from 2018 to 2022, according to a study published online May 22 in...
WEDNESDAY, June 26, 2024 -- Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and...
THURSDAY, June 20, 2024 -- For patients with specific subtypes of relapsed or refractory diffuse large B-cell lymphoma (DLBCL), treatment with...
THURSDAY, June 20, 2024 -- The prevalence of mental health variables is higher among adults who report loneliness, with the highest prevalence of...
FRIDAY, June 28, 2024 -- Precision-guided treatment improves outcomes for children with high-risk cancer, according to a study published online June...
THURSDAY, June 27, 2024 -- Only one-quarter of adults who needed opioid use disorder (OUD) treatment in 2022 received medications for OUD, according...